Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.
Facility for the research community, with instrumens, protocols, educational materials and message boards. Includes links to services and project feasibility submission at Michigan State University, East Lansing.
Experts from different sectors of basic or clinical fields. Includes human 2-D PAGE databases for proteome analysis in health and disease, galleries protocols and related links.
Established by scientists from the Weizmann Institute of Science, the center provides its unique three-dimensional proteomics structure capability to Israeli academia and industry.
The CPC is funded by the NIH/NHLBI to analyze protein variations caused by oxidative stress, a condition influenced by smoking, exposure to ionizing radiation, and other lifestyle and environmental processes. Includes related links at Boston, Massachusetts.
Facility for clinical targeted research, also offering protein extraction, 2D-PAGE with fluorescent or silver stain, excision and bioinformatic identification by MALDI-MS fingerprinting. Includes fees, patents and publications at Kentucky.
The lab focuses on protein folding problems using mathematical models, high speed computers, computer graphics, and artificial intelligence computer languages.
The center's mission is to apply state-of-the-art methods and to develop new approaches and techniques to investigate the proteomics of adaptation to ischemia and hypoxia, a biological process of general relevance to heart, lung and blood diseases.
The center focuses on improving existing and developing new proteomics technologies related to the adaptive changes in protein signaling that occur in response to substance abuse.
PPI is working to define the research and regulatory agenda required to advance the exploration and diagnostic use of the human plasma proteome. Includes introduction to projects and participants' contacts in Washington DC.